Catalyst Wire Dossier Catalyst Wire Dossier

efaproxiral (RSR13)

efaproxiral · Spectrum Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for efaproxiral (RSR13), covering 2013-05-10 to 2013-05-10. Get the full timeline:

Most recent: Clinical Trial Update: Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer [Phase 3]

See pricing